BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2020

View Archived Issues

Synthetic Biologics enters exclusive option to license intellectual property for use of SYN-020

Read More

Institut Pasteur announces advancements in the development of MV-SARS-CoV-2 vaccine

Read More

Vir Biotechnology initiates first-in-human study of VIR-3434

Read More

Discovery of selective Mdm2-inhibiting peptides maps a pathway to exploitation of the target

Read More

AhR is a therapeutic target in psoriasis

Read More

NantKwest and ImmunityBio agreement to support development COVID-19 therapeutics and vaccines

Read More

Apellis starts phase I/II study of APL-9 in severe COVID-19

Read More

FDA agrees to phase II study of OP-101 in severe COVID-19

Read More

FDA gives IND clearance for CERC-002 in COVID-19-induced ARDS

Read More

Positive interim analysis data for Auxora in patients with severe COVID-19 pneumonia

Read More

resTORbio initiates study of RTB-101 as antiviral prophylaxis to reduce severity of COVID-19

Read More

SAB Biotherapeutics plans to initiate clinical testing of potential COVID-19 therapeutic

Read More

Inhibition of Dyrk1a delays onset of amyloid and tau pathologies

Read More

Beijing FivePlus Molecular Medicine Institute patents APOC2 gene therapy

Read More

GenMont Biotech describes new probiotic compositions

Read More

NOX4 inhibition ameliorates memory deficits in Alzheimer's disease

Read More

Kallikrein-6 as novel pharmacological target to promote remyelination in multiple sclerosis

Read More

Ottawa Hospital Research Institute, United Therapeutics disclose MSCs overexpressing AOAH

Read More

Modified GLP-1 fusion proteins presented by Ajinomoto, XL-protein

Read More

STC.UNM presents antibodies targeting cholecystokinin B receptors

Read More

Positive topline data from NORA study of Zejula in Chinese patients with ovarian cancer

Read More

Initiation of Singapore study of Leukine in respiratory illness associated with COVID-19

Read More

French regulatory authorities approve the REVocan study of AsiDNA

Read More

Neurotrope and NIH launch long-term study of bryostatin in patients with AD

Read More

Metformin extends survival in mutant mCRC patients

Read More

Genmab presents positive topline data from ANDROMEDA study of daratumumab

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 4, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing